Ginsenoside Rg3-encapsulated pegylated niosomes exhibit multimodal therapeutic potential in Alzheimer’s disease
Mahmood Barani, Farshid Zargari, Shekoufeh Mirinejad, Fatemeh Madani, Mohammad Reza Hajinezhad, Saman Sargazi · 2025
Read Ginsenoside Rg3-encapsulated pegylated niosomes exhibit multimodal therapeutic potential in Alzheimer’s disease by Mahmood Barani, Farshid Zargari, Shekoufeh Mirinejad, Fatemeh Madani, Mohammad Reza Hajinezhad, Saman Sargazi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12820278.txt.
Description
Mahmood Barani and co-authors pack a ginseng compound into tiny fat bubbles to treat Alzheimer's disease, in work from twenty twenty-five. The compound, called ginsenoside Rg3, can slow the build up of the amyloid protein that marks the disease. Getting it to the brain in useful amounts is the hard part.
The coated bubbles trapped most of the drug and released it slowly over two days. In cell tests, the formula cut stress and death signals after amyloid exposure. In animals, brain tissue and the blood brain barrier looked better preserved, though behavior scores did not shift firmly. Computer models confirmed the bubbles form on their own with the drug inside. The carrier shows promise for brain delivery.
Catalog record
| CREATOR | Mahmood Barani, Farshid Zargari, Shekoufeh Mirinejad, Fatemeh Madani, Mohammad Reza Hajinezhad, Saman Sargazi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |